financetom
Business
financetom
/
Business
/
Canada's Scotiabank posts strong quarter on higher interest income
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Canada's Scotiabank posts strong quarter on higher interest income
Aug 26, 2025 3:27 AM

Aug 26 (Reuters) - Canadian lender Bank of Nova Scotia ( BNS )

reported a rise in third-quarter profit on Tuesday, as

it earned higher interest amid easing trade tensions with the

United States.

On an adjusted basis, it reported a profit of C$2.52 billion

($1.82 billion), or C$1.88 per share, for the quarter ended

July 31, compared with C$2.19 billion, or C$1.63 per share, a

year earlier.

($1 = 1.3817 Canadian dollars)

(Reporting by Ateev Bhandari in Bengaluru; Editing by Sriraj

Kalluvila)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Update: Sight Sciences Says it Obtained $34 Million Patent Infringement Verdict Against Alcon -- Shares Jump
Update: Sight Sciences Says it Obtained $34 Million Patent Infringement Verdict Against Alcon -- Shares Jump
Apr 29, 2024
11:21 AM EDT, 04/29/2024 (MT Newswires) -- (Updates with Alcon's ( ALC ) reply in the fourth paragraph and current stock movement in the fifth paragraph.) Sight Sciences ( SGHT ) said Monday it has received a jury trial verdict of $34 million related to the patent-infringement case it filed in September 2021 against Alcon ( ALC ) in the...
X4 Pharmaceuticals' Xolremdi Approved by FDA For WHIM Syndrome
X4 Pharmaceuticals' Xolremdi Approved by FDA For WHIM Syndrome
Apr 29, 2024
11:19 AM EDT, 04/29/2024 (MT Newswires) -- X4 Pharmaceuticals ( XFOR ) said Monday that the US Food and Drug Administration has approved Xolremdi for use in patients 12 years and older with warts, hypogammaglobulinemia, infections and myelokathexis, or WHIM, syndrome to raise circulating mature neutrophils and lymphocytes. The approval was based on results of a late-stage trial that showed...
Update: Market Chatter: Boeing Initiates Dollar Bond Sale After Reporting Cash Burn
Update: Market Chatter: Boeing Initiates Dollar Bond Sale After Reporting Cash Burn
Apr 29, 2024
11:18 AM EDT, 04/29/2024 (MT Newswires) -- (Updates with additional information, response from Boeing ( BA ) and latest share price movement.) Boeing ( BA ) is working on a major bond sale, its first since reporting a Q1 loss and $3.9 billion of cash burn last week, Bloomberg News reported Monday, citing a person familiar with the matter. The...
Aquestive Therapeutics Obtains FDA Approval for Libervant to Treat Seizure in Children
Aquestive Therapeutics Obtains FDA Approval for Libervant to Treat Seizure in Children
Apr 29, 2024
11:19 AM EDT, 04/29/2024 (MT Newswires) -- Aquestive Therapeutics ( AQST ) said Monday that the US Food and Drug Administration has approved Libervant Buccal Film to treat intermittent, stereotypic episodes of frequent seizure activity, which are distinct from a patient's usual seizure pattern, in epileptic patients aged 2 years to 5 years old. Aquestive Chief Executive Officer Daniel Barber...
Copyright 2023-2026 - www.financetom.com All Rights Reserved